# Alto Neuroscience, Inc. (ANRO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ANRO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -53.88M | $ -47.41M | $ 7.05M | $ 219.25M |
| 2025 | $ 0 | $ -64.75M | $ -53.03M | $ 23.96M | $ 151.14M |
| 2024 | $ 0 | $ -64.57M | $ -52.03M | $ 16.94M | $ 151.46M |
| 2023 | $ 0 | $ -39.25M | $ -36.67M | $ 9.99M | $ -71.67M |
| 2022 | $ 0 | $ -8.55M | $ -6.80M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.16 |
| Current Ratio | 14.85 |

## Other views

- [Metrics](https://sponda.capital/en/ANRO.md)
- [Charts](https://sponda.capital/en/ANRO/charts.md)
- [Compare](https://sponda.capital/en/ANRO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.